TABLE 3.
Study type | Findings | Ref. |
---|---|---|
Experimental study | NEP inhibitors deteriorate glucose homeostasis and insulin sensitivity. | Becker et al 45 |
Experimental study | NEP‐deficient mice are susceptible to the development of obesity and impairment of glucose tolerance. | Poorgolizadeh et al 69 |
Experimental study |
NEP inhibitors did not improve glycemic indices in rats. |
Simonsen et al 39 |
Experimental study | NEP inhibitors did not improve glucose homeostasis and insulin sensitivity in rats with T2DM. | Davidson et al 70 |
A prospective study | Administration of ARNIs lead to hyperglycemia in T2DM patients. | Albrechtsen et al 15 |
A prospective, crossover study | ARNIs worsen postprandial glucose control in T2DM patients. | Wewer et al 71 |
Abbreviations: ARNI, angiotensin receptor/neprilysin inhibitor; NEP, neprilysin; T2DM. type 2 diabetes mellitus.